MetaCap

Alto Neuroscience (ANRO) vs City Therapeutics (CTY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

City Therapeutics is the larger company by market cap ($1.03 billion vs $1.02 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANRO+15.63%CTY-13.75%
+45%+8%-30%
Oct 16, 20261 yearNov 20, 2026
ANRO+15.63%CTY-13.75%
+37%+8%-22%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANRO versus CTY key metrics
MetricANROCTY
Share price$25.37$19.32
Market cap$1.02B$1.03B
1-day change-4.30%+5.29%
YTD return+42.53%—
1-year return+91.47%—
EPS (TTM)$-2.32$-2.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-63.24M—
52-week high$37.48$23.88
52-week low$12.51$15.81
Distance from 52-week high-32.31%-19.10%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+52.42%+93.22%
Average volume614.92K328.87K
Shares outstanding40.11M53.39M
Employees6875
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Alto Neuroscience

ANRO stock →

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees

About City Therapeutics

CTY stock →

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules.

Health Care · Biotechnology: Pharmaceutical Preparations · 75 employees

ANRO vs CTY FAQ

Which is bigger, Alto Neuroscience or City Therapeutics?

City Therapeutics (CTY) is larger, with a market capitalization of $1.03B compared with $1.02B for Alto Neuroscience (ANRO).

Are Alto Neuroscience and City Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons